Prognostic Significance of CD31 Expression in Patients with Non-Small-Cell-Lung Cancer

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Advances in Lung Cancer

ISSN Print: 2169-2718
ISSN Online: 2169-2726
www.scirp.org/journal/alc
E-mail: alc@scirp.org

Citations h5-index & Ranking*

Journals Menu

"Prognostic Significance of CD31 Expression in Patients with Non-Small-Cell-Lung Cancer"
written by Alexander Emmert, Angelika Oellerich, Laszlo Füzesi, Regina Waldmann-Beushausen, Hanibal Bohnenberger, Friedrich A. Schöndube, Bernhard C. Danner,
published by Advances in Lung Cancer, Vol.5 No.3, 2016

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Прогностическая значимость комплексной оценки экспрессии Ki-67, фактора некроза опухоли α, CD20 и CD31 при немелкоклеточном раке легкого
	Успехи …, 2021

[2]	Expression Profiles of VEGF-A, CD31 and GRP78 in Non-Small Cell Lung Cancer.
	2020

[3]	Multidrogorresistencia de la tuberculosis en un paciente y proceso de atención de enfermería
	2019

[4]	Ekspresija tumorskih markera, pojava recidiva i stopa petogodišnjeg preživljavanja hirurški lečenih pacijenata sa nesitnoćelijskim karcinomom pluća
	2017

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Advances in Lung Cancer

Advances in Lung Cancer

Journals Menu

Home

About SCIRP

Service

Policies

[1]	GRP78 is Overexpressed in Non-small Cell Lung Cancer Tissues and is Associated with High VEGF Expression in Squamous Cell Carcinoma: A Pilot Study Current Cancer Drug Targets, 2023 DOI:10.2174/1568009623666230418111020